Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

Abstract:

:Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established procedure used in the management of complications of portal hypertension. Although the most robust evidence supports the use of TIPS as salvage therapy in variceal hemorrhage, secondary prophylaxis of variceal bleeding, and treatment of refractory ascites, there is also data to suggest its efficacy in other indications such as hepatic hydrothorax, hepatorenal syndrome, and Budd-Chiari syndrome. Recent literature also suggests that TIPS may improve survival for certain subpopulations if placed early after variceal bleeding. This article provides an updated evidence-based review of the indications for TIPS. Outcomes, complications, and adequate patient selection are also discussed.

journal_name

Clin Liver Dis

journal_title

Clinics in liver disease

authors

Hung ML,Lee EW

doi

10.1016/j.cld.2019.07.004

subject

Has Abstract

pub_date

2019-11-01 00:00:00

pages

737-754

issue

4

eissn

1089-3261

issn

1557-8224

pii

S1089-3261(19)30047-9

journal_volume

23

pub_type

杂志文章,评审
  • Primary biliary cirrhosis and autoimmune cholangiopathy.

    abstract::AMA are detected in the serum of 92% to 95% of patients with PBC using indirect immunofluorescent methods. AIC is the term used to describe the 5% to 8% of AMA-negative PBC patients who uniformly have ANA and SMA. Recent applications of more sensitive and specific tests to detect serum AMA have shown that most, if not...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/S1089-3261(03)00132-6

    authors: Vierling JM

    更新日期:2004-02-01 00:00:00

  • Cholestasis and alcoholic liver disease.

    abstract::Histologic cholestasis and clinical jaundice may be seen in all stages of alcoholic liver disease. In rare cases, isolated cholestasis without significant steatosis, hepatitis, or cirrhosis is identified in an alcoholic patient. The mechanisms of ethanol-induced cholestasis are not well studied but may involve compres...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70086-6

    authors: Tung BY,Carithers RL Jr

    更新日期:1999-08-01 00:00:00

  • Understanding and Treating Pruritus in Primary Biliary Cholangitis.

    abstract::Pruritus is a common symptom with primary biliary cholangitis. Research has focused on refining understanding of the neurohumoral pathways involved in transduction of pruritus from peripheral cutaneous receptors to the central nervous system, and identifying modulating drugs. Current treatments have variable efficacy ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.03.005

    authors: Carrion AF,Rosen JD,Levy C

    更新日期:2018-08-01 00:00:00

  • Nonviral or Drug-Induced Etiologies of Acute Liver Failure.

    abstract::Acute liver failure (ALF) is a rare but highly fatal condition. The most common causes include drug-induced and viral hepatitis, but other less common etiologies, especially autoimmune hepatitis, Budd-Chiari syndrome, and Wilson disease, need to be considered. Because diagnosis is frequently tied to potential for reve...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.01.008

    authors: Rosenblatt R,Brown RS Jr

    更新日期:2018-05-01 00:00:00

  • Chronic hepatitis B: past, present, and future.

    abstract::There have been major advances in the field of hepatitis B (HBV) over the last few decades. These advances have resulted in the understanding of the natural history of chronic HBV infection, effective vaccines against the virus, sensitive assays for screening and monitoring of treatment, and effective treatments for v...

    journal_title:Clinics in liver disease

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.cld.2010.05.003

    authors: Lai M,Liaw YF

    更新日期:2010-08-01 00:00:00

  • The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.

    abstract::The Model for End-stage Liver Disease (MELD) has been demonstrated to be an excellent predictor of survival in patients who have end-stage liver disease. It is derived from the international normalized ratio (INR) of prothrombin time, serum creatinine, and serum total bilirubin. The major use of the MELD score is to p...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章

    doi:10.1016/j.cld.2008.09.001

    authors: Kamath PS,Kim WR

    更新日期:2009-02-01 00:00:00

  • Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.

    abstract::Nonalcoholic fatty liver disease is emerging as the most common cause of chronic liver disease worldwide. This trend is, in part, secondary, to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome. Other risk factors include age, gender, race/ethnicity, genetic predisposition, and polycystic ovari...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.08.008

    authors: Lim HW,Bernstein DE

    更新日期:2018-02-01 00:00:00

  • Cirrhosis and Portal Hypertension in the Pediatric Population.

    abstract::Cirrhosis is a complex process in which the architecture of the liver is replaced by structurally abnormal nodules due to cirrhosis. Cirrhosis frequently leads to the development of portal hypertension. In children, portal hypertension may be caused by a wide range of etiologies, including extrahepatic portal vein obs...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.06.007

    authors: Chapin CA,Bass LM

    更新日期:2018-11-01 00:00:00

  • Telaprevir: hope on the horizon, getting closer.

    abstract::Standard therapy with pegylated interferon and ribavirin for chronic hepatitis C is effective in 40% to 50% of individuals with genotype 1 hepatitis C virus (HCV) infection and is associated with significant treatment-related toxicities. Newly developed small molecules that target key enzymes essential for HCV replica...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2009.05.009

    authors: Weisberg IS,Jacobson IM

    更新日期:2009-08-01 00:00:00

  • The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.

    abstract::Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that can be divided into benign steatosis or nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Elastography and scoring systems based on clinical features and routine biochemical testing can be used to assess fibrosis in patient...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.08.006

    authors: Gunn NT,Shiffman ML

    更新日期:2018-02-01 00:00:00

  • Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy.

    abstract::Both covert hepatic encephalopathy (CHE) and overt hepatic encephalopathy (OHE) impair the ability to operate machinery. The legal responsibilities of US physicians who diagnose and treat patients with hepatic encephalopathy vary among states. It is imperative that physicians know the laws regarding reporting in their...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.04.004

    authors: Vierling JM

    更新日期:2015-08-01 00:00:00

  • Liver Transplantation and Bariatric Surgery: Best Approach.

    abstract::Obesity has become increasingly prevalent, and the number of obese patients in need of liver transplant is expected to continue to increase. In addition, liver disease due to nonalcoholic fatty liver disease is expected to become the leading cause of liver transplantation in the near future. However, obesity remains a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.12.001

    authors: Suraweera D,Dutson E,Saab S

    更新日期:2017-05-01 00:00:00

  • Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

    abstract::Because of shared routes of transmission, hepatitis C virus (HCV) coinfection is common among HIV-infected persons. Because of the effectiveness of antiretroviral therapy, chronic HCV has now emerged as a major cause of morbidity and mortality in this population. Because chronic HCV is highly prevalent among HIV-infec...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2008.03.009

    authors: Lo Re V 3rd,Kostman JR,Amorosa VK

    更新日期:2008-08-01 00:00:00

  • Xenotransplantation of the liver.

    abstract::Xenotransplantation of the liver, in its broadest conception, might involve the transplantation of an intact organ or xenogeneic hepatocytes, or the use of an intact xenogeneic liver or cells as an ex vivo "device." The indications for xenotransplantation include not only hepatic failure but also, potentially, the tre...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70135-5

    authors: Kanai N,Platt JL

    更新日期:2000-08-01 00:00:00

  • The HCV NS5B nucleoside and non-nucleoside inhibitors.

    abstract::This article introduces one of the most diverse classes of direct-acting antivirals for hepatitis C, the nucleoside and non-nucleoside NS5B polymerase inhibitors. Through a systematic review of the published literature, we describe their structure, mechanism of action, issues with resistance, and clinical effectivenes...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2011.05.003

    authors: Membreno FE,Lawitz EJ

    更新日期:2011-08-01 00:00:00

  • Alcohol and the Law.

    abstract::In the intersection of alcohol ingestion with the law, medical ethics, and public safety, physicians are often unsure about how to proceed. Physicians' primary focus should be on patient education with an ethical and legal duty to warn the patient of the adverse effects of alcohol. Warning third parties of potential h...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.09.002

    authors: Balakrishnan M,Pappas SC

    更新日期:2019-02-01 00:00:00

  • Management of alcohol abuse.

    abstract::This article reviews the spectrum of alcohol use disorders. The pharmacologic properties of ethanol and its metabolism, and the historical, physical, and laboratory elements that may help diagnose an alcohol use disorder are examined. The concepts of motivational interviewing and stages of change are mentioned, along ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2012.08.006

    authors: Albanese AP

    更新日期:2012-11-01 00:00:00

  • Immunopathogenesis of hepatitis C virus infection.

    abstract::HCV infection becomes persistent in many patients who are otherwise immune competent. There is increasing support for potential contribution of innate immune response and viral interference with its components to the subsequent outcome. As for the adaptive immune response, humoral immunity may be largely ineffective d...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00068-5

    authors: Chang KM

    更新日期:2003-02-01 00:00:00

  • Hepatobiliary manifestations of critically ill and postoperative patients.

    abstract::Liver dysfunction is common in both the critically ill and postoperative patient. Metabolic derangements secondary to sepsis, poor hepatic perfusion, total parenteral nutrition, in addition to hemodynamic and anesthetic-induced changes that occur during surgery, can cause liver damage ranging from small self-limited a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.09.004

    authors: Aronsohn A,Jensen D

    更新日期:2011-02-01 00:00:00

  • Surgery versus transjugular intrahepatic portal systemic shunt in the treatment of severe variceal bleeding.

    abstract::The management of patients who have portal hypertension has changed dramatically over the last 2 decades. Pharmacologic therapy benefits the patient by reducing the risk for an initial bleed, improving the management of an acute bleed, and in reducing the risk for a rebleed. Endoscopic management has improved progress...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2006.08.020

    authors: Henderson JM

    更新日期:2006-08-01 00:00:00

  • Mechanisms of ascites formation.

    abstract::Ascites is the most common complication of cirrhosis. It is associated with profound changes in the splanchnic and systemic circulation and with renal abnormalities. The development of ascites is related to the existence of severe sinusoidal portal hypertension that causes marked splanchnic arterial vasodilation and a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70118-5

    authors: Cárdenas A,Bataller R,Arroyo V

    更新日期:2000-05-01 00:00:00

  • Pediatric liver transplantation.

    abstract::In the past two decades, pediatric liver transplantation has become the state-of-the-art operation with anticipated success and limited mortality. The future success of pediatric liver transplantation will require thoughtful solutions to the delicate balance of risk to donors and recipients, the complex needs of the a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2005.10.004

    authors: Tiao G,Ryckman FC

    更新日期:2006-02-01 00:00:00

  • Contemporary assessment of hepatic fibrosis.

    abstract::Newer noninvasive tests have begun to replace liver biopsy for staging purposes. The clinician must evaluate these tools and apply them to individual patients. None of these modalities give the exact same staging of fibrosis as a liver biopsy, but they are excellent tools for risk stratification. Still, it should be r...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2014.09.007

    authors: Bonder A,Tapper EB,Afdhal NH

    更新日期:2015-02-01 00:00:00

  • Pathogenesis of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangiopathy.

    abstract::Autoimmune liver diseases have much in common with each other, and there are clear associations with genetic haplotypes. Elegant studies have shown autoimmune liver disease induced by viruses and drugs. Although there is evidence for nonimmunological events precipitating immune disease, especially in primary sclerosin...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70005-2

    authors: Peters MG

    更新日期:1998-05-01 00:00:00

  • Serologic and molecular diagnosis of hepatitis B virus.

    abstract::Serologic assays for HBV are the mainstay diagnostic tools for HBV infection. However, the advent of molecular biology-based techniques has added a new dimension to the diagnosis and treatment of patients with chronic HBV infection. Over the past decade, improvements in molecular technology, permitting detection of as...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.02.001

    authors: Servoss JC,Friedman LS

    更新日期:2004-05-01 00:00:00

  • Treatment of recurrent hepatitis C after liver transplantation.

    abstract::Chronic hepatitis C virus (HCV) infection is the most common indication for liver transplantation in the United States and Europe, and more than 20,000 patients worldwide have undergone transplantation for complications of chronic hepatitis C. In North America, HCV accounts for 15% to 50% of the liver transplants perf...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2005.05.004

    authors: Biggins SW,Terrault NA

    更新日期:2005-08-01 00:00:00

  • Molecular virology of the hepatitis C virus: implication for novel therapies.

    abstract::The study of hepatitis C virus (HCV) molecular virology is helping to shape the future of our anti-HCV strategies by identifying new antiviral targets. With the advent of agents that specifically target individual HCV proteins, HCV-specific therapy has arrived. Key to these efforts is the development of high-efficienc...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2005.05.013

    authors: Glenn JS

    更新日期:2005-08-01 00:00:00

  • Current status of pediatric liver transplantation.

    abstract::Increased survival for young liver transplant recipients has greatly improved. Increasing success has led to broader indications, thereby increasing the number of potential recipients. Pediatric liver centers are developing new strategies to cope with the ever-increasing demands for suitable size appropriate grafts. U...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70125-2

    authors: Abramson O,Rosenthal P

    更新日期:2000-08-01 00:00:00

  • Hepatitis C virus. The importance of viral heterogeneity.

    abstract::Although recent evidence indicates that the quasispecies nature of HCV constitutes a critical strategy for the virus to survive in the host, the mechanisms of viral persistence remain unknown. Similarly, the correlates of immune protection in a limited proportion of individuals who succeed in clearing HCV are still la...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70200-2

    authors: Farci P

    更新日期:2001-11-01 00:00:00

  • Screening for cancer in viral hepatitis.

    abstract::Early diagnosis of HCC is possible because certain risk factors for this tumor are known and because sensitive and relatively inexpensive diagnostic tools are available. Early diagnosis of HCC is also possible because of the long phase of asymptomatic tumor growth and the tumor's tendency to grow as a solitary mass in...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70156-2

    authors: Colombo M

    更新日期:2001-02-01 00:00:00